Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BRTX
BRTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BRTX News
Regulatory Approvals and Collaborations in Biotech Sector
1d ago
NASDAQ.COM
BioRestorative Completes Phase 2 Trial for BRTX-100
4d ago
NASDAQ.COM
BioRestorative Completes Patient Dosing in BRTX-100 Clinical Trial
4d ago
NASDAQ.COM
BioRestorative Completes Phase 2 Trial for BRTX-100 in Chronic Lumbar Disc Disease
4d ago
Newsfilter
BioRestorative Completes Phase 2 Trial for BRTX-100 in Chronic Lumbar Disc Disease
4d ago
Yahoo Finance
BioRestorative Presents New MSC-Derived Exosome Data
May 13 2026
Newsfilter
BioRestorative Reports Positive Phase 2 Trial Results for BRTX-100
May 07 2026
Newsfilter
BioRestorative to Present New Data at ISCT 2026 Annual Meeting
Apr 30 2026
Newsfilter
BioRestorative Partners with Dermatologist to Enhance BioCosmeceutical Platform
Apr 21 2026
NASDAQ.COM
Zevra Therapeutics Reports Strong Q4 Earnings, Shares Surge
Mar 10 2026
Benzinga
BioRestorative Secures Patent Protection in Australia
Feb 24 2026
Newsfilter
BioRestorative Closes Public Offering of 14.29 Million Shares
Feb 14 2026
Yahoo Finance
BioRestorative Closes $5 Million Public Offering of 14.3 Million Shares
Feb 14 2026
Newsfilter
U.S. Stocks Decline Midway, Nasdaq Drops Over 350 Points
Feb 12 2026
Benzinga
U.S. Stocks Mostly Higher in Morning Trade, Dow Up Over 200 Points
Feb 12 2026
Benzinga
Fastly Reports Strong Quarterly Earnings Exceeding Expectations
Feb 12 2026
Benzinga
Show More News
